Vitamin K2 as MK-7 shown to improve endothelial function
New MenaQ7 mouse study publishes, furthering argument of K2 as MK-7 as a cardio-protective nutrient by highlighting new pharmacological activity.OSLO, NORWAY AND EDISON, NJ (12 NOVEMBER 2019) — Adding to the already-strong body of clinical evidence confirming Vitamin K2 as MK-7 inhibits arterial calcification and acts as an antioxidant, a study recently published in Vascular Pharmacology shows K2 as MK-7 boosts nitric oxide (NO), improving NO-dependent endothelial function. The study used MenaQ7® Vitamin K2 as MK-7, supplied by NattoPharma. Endothelial dysfunction has been associated